The U.K. biotech IMU Biosciences will help create a large and detailed immune dataset for 80,000 people in the UK Biobank.

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

New research reveals how autoimmune kidney inflammation develops and identifies an antibody-based strategy that may prevent ...

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.

GLP-1 medications may reduce complications after surgery, with new research linking their use to fewer cardiovascular events ...

An analysis of multiple cancer types has revealed mitochondrial DNA copy number as a key determinant of mutational load and ...

Differences in the bacteria living in the mouth and airways may be associated with the severity of long COVID.

Statin use was associated with a lower risk of open-angle glaucoma and less need for surgery, laser treatment, and ...

At the 2026 Cell and Gene Meeting on the Mesa, biotech executives focused on value creation with differentiated technologies ...

A single tRNA can influence whether prostate cancer cells mutate and become difficult to treat with standard therapies.

A short peptide reduced chronic pain-like behaviors in mice without disrupting the acute pain signals that help protect ...

As one of the world’s most common genetic diseases, developing treatments for autosomal dominant polycystic kidney disease (ADPKD) is both a daunting and important task. Much research has been done to ...